Cargando…

DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists

Drug resistance represents a major obstacle to therapeutic innovations and is a prevalent feature in prostate cancer (PCa). Androgen receptors (ARs) are the hallmark therapeutic target for prostate cancer modulation and AR antagonists have achieved great success. However, rapid emergence of resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaduangrat, Nalini, Anuwongcharoen, Nuttapat, Charoenkwan, Phasit, Shoombuatong, Watshara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163717/
https://www.ncbi.nlm.nih.gov/pubmed/37149650
http://dx.doi.org/10.1186/s13321-023-00721-z
_version_ 1785037941290041344
author Schaduangrat, Nalini
Anuwongcharoen, Nuttapat
Charoenkwan, Phasit
Shoombuatong, Watshara
author_facet Schaduangrat, Nalini
Anuwongcharoen, Nuttapat
Charoenkwan, Phasit
Shoombuatong, Watshara
author_sort Schaduangrat, Nalini
collection PubMed
description Drug resistance represents a major obstacle to therapeutic innovations and is a prevalent feature in prostate cancer (PCa). Androgen receptors (ARs) are the hallmark therapeutic target for prostate cancer modulation and AR antagonists have achieved great success. However, rapid emergence of resistance contributing to PCa progression is the ultimate burden of their long-term usage. Hence, the discovery and development of AR antagonists with capability to combat the resistance, remains an avenue for further exploration. Therefore, this study proposes a novel deep learning (DL)-based hybrid framework, named DeepAR, to accurately and rapidly identify AR antagonists by using only the SMILES notation. Specifically, DeepAR is capable of extracting and learning the key information embedded in AR antagonists. Firstly, we established a benchmark dataset by collecting active and inactive compounds against AR from the ChEMBL database. Based on this dataset, we developed and optimized a collection of baseline models by using a comprehensive set of well-known molecular descriptors and machine learning algorithms. Then, these baseline models were utilized for creating probabilistic features. Finally, these probabilistic features were combined and used for the construction of a meta-model based on a one-dimensional convolutional neural network. Experimental results indicated that DeepAR is a more accurate and stable approach for identifying AR antagonists in terms of the independent test dataset, by achieving an accuracy of 0.911 and MCC of 0.823. In addition, our proposed framework is able to provide feature importance information by leveraging a popular computational approach, named SHapley Additive exPlanations (SHAP). In the meanwhile, the characterization and analysis of potential AR antagonist candidates were achieved through the SHAP waterfall plot and molecular docking. The analysis inferred that N-heterocyclic moieties, halogenated substituents, and a cyano functional group were significant determinants of potential AR antagonists. Lastly, we implemented an online web server by using DeepAR (at http://pmlabstack.pythonanywhere.com/DeepAR). We anticipate that DeepAR could be a useful computational tool for community-wide facilitation of AR candidates from a large number of uncharacterized compounds. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-023-00721-z.
format Online
Article
Text
id pubmed-10163717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-101637172023-05-07 DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists Schaduangrat, Nalini Anuwongcharoen, Nuttapat Charoenkwan, Phasit Shoombuatong, Watshara J Cheminform Research Drug resistance represents a major obstacle to therapeutic innovations and is a prevalent feature in prostate cancer (PCa). Androgen receptors (ARs) are the hallmark therapeutic target for prostate cancer modulation and AR antagonists have achieved great success. However, rapid emergence of resistance contributing to PCa progression is the ultimate burden of their long-term usage. Hence, the discovery and development of AR antagonists with capability to combat the resistance, remains an avenue for further exploration. Therefore, this study proposes a novel deep learning (DL)-based hybrid framework, named DeepAR, to accurately and rapidly identify AR antagonists by using only the SMILES notation. Specifically, DeepAR is capable of extracting and learning the key information embedded in AR antagonists. Firstly, we established a benchmark dataset by collecting active and inactive compounds against AR from the ChEMBL database. Based on this dataset, we developed and optimized a collection of baseline models by using a comprehensive set of well-known molecular descriptors and machine learning algorithms. Then, these baseline models were utilized for creating probabilistic features. Finally, these probabilistic features were combined and used for the construction of a meta-model based on a one-dimensional convolutional neural network. Experimental results indicated that DeepAR is a more accurate and stable approach for identifying AR antagonists in terms of the independent test dataset, by achieving an accuracy of 0.911 and MCC of 0.823. In addition, our proposed framework is able to provide feature importance information by leveraging a popular computational approach, named SHapley Additive exPlanations (SHAP). In the meanwhile, the characterization and analysis of potential AR antagonist candidates were achieved through the SHAP waterfall plot and molecular docking. The analysis inferred that N-heterocyclic moieties, halogenated substituents, and a cyano functional group were significant determinants of potential AR antagonists. Lastly, we implemented an online web server by using DeepAR (at http://pmlabstack.pythonanywhere.com/DeepAR). We anticipate that DeepAR could be a useful computational tool for community-wide facilitation of AR candidates from a large number of uncharacterized compounds. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-023-00721-z. Springer International Publishing 2023-05-06 /pmc/articles/PMC10163717/ /pubmed/37149650 http://dx.doi.org/10.1186/s13321-023-00721-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Schaduangrat, Nalini
Anuwongcharoen, Nuttapat
Charoenkwan, Phasit
Shoombuatong, Watshara
DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title_full DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title_fullStr DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title_full_unstemmed DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title_short DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
title_sort deepar: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163717/
https://www.ncbi.nlm.nih.gov/pubmed/37149650
http://dx.doi.org/10.1186/s13321-023-00721-z
work_keys_str_mv AT schaduangratnalini deeparanoveldeeplearningbasedhybridframeworkfortheinterpretablepredictionofandrogenreceptorantagonists
AT anuwongcharoennuttapat deeparanoveldeeplearningbasedhybridframeworkfortheinterpretablepredictionofandrogenreceptorantagonists
AT charoenkwanphasit deeparanoveldeeplearningbasedhybridframeworkfortheinterpretablepredictionofandrogenreceptorantagonists
AT shoombuatongwatshara deeparanoveldeeplearningbasedhybridframeworkfortheinterpretablepredictionofandrogenreceptorantagonists